EP 1117791 A2 20010725 - CANCER ASSOCIATED ANTIGENS AND USES THEREFOR
Title (en)
CANCER ASSOCIATED ANTIGENS AND USES THEREFOR
Title (de)
ANTIGENE, DIE IM ZUSAMMENHANG MIT KREBS AUFTRETEN
Title (fr)
ANTIGENES ASSOCIES AU CANCER ET LEURS UTILISATIONS
Publication
Application
Priority
- US 9922873 W 19991004
- US 16630098 A 19981005
- US 16635098 A 19981005
Abstract (en)
[origin: WO0020587A2] Cancer associated antigens have been identified by autologous antibody screening of libraries of nucleic acids expressed in renal cancer cells using antisera from cancer patients. The invention relates to nucleic acids and encoded polypeptides which are cancer associated antigens expressed in patients afflicted with renal cancer. The invention provides, inter alia, isolated nucleic acid molecules, expression vectors containing those molecules and host cells transfected with those molecules. The invention also provides isolated proteins and peptides, antibodies to those proteins and peptides and cytotoxic T lymphocytes which recognize the proteins and peptides. Fragments of the foregoing including functional fragments and variants also are provided. Kits containing the foregoing molecules additionally are provided. The molecules provided by the invention can be used in the diagnosis, monitoring, research, or treatment of conditions characterized by the expression of one or more cancer associated antigens.
IPC 1-7
C12N 15/12; C07K 14/47; A61K 31/70; A61K 35/12; A61K 38/13; C07K 16/18; G01N 33/574; C12Q 1/68
IPC 8 full level
A61K 31/711 (2006.01); A61K 35/76 (2015.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/08 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/574 (2006.01); G01N 33/577 (2006.01); A61K 35/00 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP KR)
A61K 39/46 (2023.05 - EP KR); A61K 39/4611 (2023.05 - EP KR); A61K 39/464499 (2023.05 - EP KR); A61P 35/00 (2018.01 - EP); C07K 14/47 (2013.01 - EP); C12Q 1/68 (2013.01 - KR); C12Q 1/6886 (2013.01 - EP); G01N 33/57488 (2013.01 - EP); G01N 33/57492 (2013.01 - EP); A61K 35/00 (2013.01 - EP); A61K 38/00 (2013.01 - EP); A61K 39/00 (2013.01 - EP KR); A61K 48/00 (2013.01 - EP); A61K 2035/11 (2013.01 - EP); C12Q 2600/158 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0020587 A2 20000413; WO 0020587 A3 20001012; AU 6505599 A 20000426; CA 2344995 A1 20000413; CN 1367830 A 20020904; EP 1117791 A2 20010725; JP 2003517274 A 20030527; KR 20010083890 A 20010903
DOCDB simple family (application)
US 9922873 W 19991004; AU 6505599 A 19991004; CA 2344995 A 19991004; CN 99811787 A 19991004; EP 99953017 A 19991004; JP 2000574682 A 19991004; KR 20017004344 A 20010404